scispace - formally typeset
A

Amy Rapkiewicz

Researcher at New York University

Publications -  46
Citations -  1737

Amy Rapkiewicz is an academic researcher from New York University. The author has contributed to research in topics: Medicine & Fine-needle aspiration. The author has an hindex of 14, co-authored 39 publications receiving 1051 citations. Previous affiliations of Amy Rapkiewicz include National Institutes of Health.

Papers
More filters
Journal ArticleDOI

Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series.

TL;DR: In this series of seven COVID-19 autopsies, thrombosis was a prominent feature in multiple organs, in some cases despite full anticoagulation and regardless of timing of the disease course, suggesting that thROMbosis plays a role very early in the disease process.
Journal ArticleDOI

Response to anti-PD1 therapy with nivolumab in metastatic sarcomas

TL;DR: In this article, the authors retrospectively analyzed a cohort of patients with relapsed metastatic/unresectable sarcomas, who were treated with nivolumab provided under a patient assistance program from the manufacturer.
Journal ArticleDOI

Coronavirus disease 2019 infection and placental histopathology in women delivering at term.

TL;DR: It is found that COVID-19 in term patients admitted to Labor and Delivery is associated with increased rates of placental histopathologic abnormalities, particularly fetal vascular malperfusion and villitis of unknown etiology, which appear to occur even among asymptomatic term patients.
Journal ArticleDOI

Pathological findings in a patient with Fabry disease who died after 2.5 years of enzyme replacement

TL;DR: The postmortem findings of a 47-year-old man with Fabry disease, an X-linked glycolipid storage disorder, who was on enzyme replacement therapy with recombinant α-galactosidase A for more than 2 years are described, concluding that, at least in this patient, repeated infusions with α-Galactoside A over a prolonged period did not appreciably clear storage material in cells other than vascular endothelial cells.
Journal ArticleDOI

The needle in the haystack: application of breast fine-needle aspirate samples to quantitative protein microarray technology.

TL;DR: Reverse‐phase protein microarray technology has been applied successfully to the quantitative analysis of breast, ovarian, prostate, and colorectal cancers using frozen surgical specimens.